Metraipolis › archive › dc_f2e8737fa22c
Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41596365
- DOI
- 10.3390/ijms27020713
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:20:34.409Z
- SHA-256 of the archived text
7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78- Stable URL of this page
https://metraipolis.com/documento/dc_f2e8737fa22c
How to cite
Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365 — Europe PMC (en), https://europepmc.org/article/MED/41596365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2e8737fa22c (Metraipolis archive dc_f2e8737fa22c, sha256 7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78)
BibTeX
@misc{dcf2e8737fa22c,
title = {Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41596365},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2e8737fa22c; sha256 7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596365. Agents can read the archived copy with the MCP tool read_document.